-
-
-
-
-
-
-
Arrowhead Pharmaceuticals Inc. (ARWR) Tops Q2 EPS by 11c
-
-
-
-
-
-
-
Arrowhead Pharma (ARWR) PT Lowered to $81 at BofA Securities
-
-
-
-
-
-
-
Arrowhead Pharma (ARWR) PT Raised to $100 at H.C. Wainwright
-
-
-
-
-
-
-
Arrowhead Pharma (ARWR) PT Raised to $84 at BofA Securities
-
-
-
-
-
-
-
Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026
-
-
-
-
-
-
-
Arrowhead Pharmaceuticals receives $200 million from Sarepta milestone
-
-
-
-
-
-
-
FDA approves Arrowhead's Redemplo to reduce triglycerides in adults with familial chylomicronemia syndrome
-
432,399 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

